Notch1-induced brain tumor models the sonic hedgehog subgroup of human medulloblastoma.

While activation of the Notch pathway is observed in many human cancers, it is unknown whether elevated Notch1 expression is sufficient to initiate tumorigenesis in most tissues. To test the oncogenic potential of Notch1 in solid tumors, we expressed an activated form of Notch1 (N1ICD) in the developing mouse brain. N1ICD;hGFAP-cre mice were viable but developed severe ataxia and seizures, and died by weaning age. Analysis of transgenic embryo brains revealed that N1ICD expression induced p53-dependent apoptosis. When apoptosis was blocked by genetic deletion of p53, 30% to 40% of N1ICD;GFAP-cre;p53(+/-) and N1ICD;GFAP-cre;p53(-/-) mice developed spontaneous medulloblastomas. Interestingly, N1ICD-induced medulloblastomas most closely resembled the sonic hedgehog subgroup of human medulloblastoma at the molecular level. Surprisingly, N1ICD-induced tumors do not maintain high levels of the Notch pathway gene expression, except for Notch2, showing that initiating oncogenic events may not be decipherable by analyzing growing tumors in some cases. In summary, this study shows that Notch1 has an oncogenic potential in the brain when combined with other oncogenic hits, such as p53 loss, and provides a novel mouse model of medulloblastoma. Cancer Res; 73(17); 5381-90. ©2013 AACR.

[1]  Darjus F. Tschaharganeh,et al.  Non-Cell-Autonomous Tumor Suppression by p53 , 2013, Cell.

[2]  Scott L. Pomeroy,et al.  Medulloblastomics: the end of the beginning , 2012, Nature Reviews Cancer.

[3]  Matthew J. Betts,et al.  Dissecting the genomic complexity underlying medulloblastoma , 2012, Nature.

[4]  Jill P. Mesirov,et al.  MEDULLOBLASTOMA EXOME SEQUENCING UNCOVERS SUBTYPE-SPECIFIC SOMATIC MUTATIONS , 2012, Nature.

[5]  F. Kirchhoff,et al.  Constitutive Notch2 signaling in neural stem cells promotes tumorigenic features and astroglial lineage entry , 2012, Cell Death and Disease.

[6]  Matthew A. Hibbs,et al.  Genome‐Wide Analysis of N1ICD/RBPJ Targets In Vivo Reveals Direct Transcriptional Regulation of Wnt, SHH, and Hippo Pathway Effectors by Notch1 , 2012, Stem cells.

[7]  Scott L. Pomeroy,et al.  Molecular subgroups of medulloblastoma: the current consensus , 2011, Acta Neuropathologica.

[8]  T. Pierfelice,et al.  Notch in the Vertebrate Nervous System: An Old Dog with New Tricks , 2011, Neuron.

[9]  T. Pierfelice,et al.  Notch3 activation promotes invasive glioma formation in a tissue site-specific manner. , 2011, Cancer research.

[10]  J. Olson,et al.  Notch signaling is not essential in sonic hedgehog-activated medulloblastoma , 2010, Oncogene.

[11]  B. Wainwright,et al.  Canonical Notch signaling is not required for the growth of Hedgehog pathway-induced medulloblastoma , 2010, Oncogene.

[12]  V. Rotter,et al.  p53‐dependent transcriptional regulation of EDA2R and its involvement in chemotherapy‐induced hair loss , 2010, FEBS letters.

[13]  Georgia Panagiotakos,et al.  Inhibition of Notch Signaling in Glioblastoma Targets Cancer Stem Cells via an Endothelial Cell Intermediate , 2010, Stem cells.

[14]  B. Sullenger,et al.  Notch Promotes Radioresistance of Glioma Stem Cells , 2009, Stem cells.

[15]  Guido Nikkhah,et al.  NOTCH Pathway Blockade Depletes CD133‐Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts , 2009, Stem cells.

[16]  Raphael Kopan,et al.  The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism , 2009, Cell.

[17]  H. Behesti,et al.  Cerebellar granule cells: insights into proliferation, differentiation, and role in medulloblastoma pathogenesis. , 2009, The international journal of biochemistry & cell biology.

[18]  S. Baker,et al.  Recurrent genomic alterations characterize medulloblastoma arising from DNA double-strand break repair deficiency , 2009, Proceedings of the National Academy of Sciences.

[19]  Dirk Troost,et al.  Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features , 2008, PloS one.

[20]  L. Liaw,et al.  Cardiovascular and Hematopoietic Defects Associated With Notch1 Activation in Embryonic Tie2-Expressing Populations , 2008, Circulation research.

[21]  Robert Machold,et al.  Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. , 2008, Cancer cell.

[22]  Tao Sun,et al.  Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. , 2008, Cancer cell.

[23]  D. Stearns,et al.  Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. , 2006, Cancer research.

[24]  Michael M. Murphy,et al.  XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[25]  N. Gaiano,et al.  Notch3 signaling initiates choroid plexus tumor formation , 2006, Oncogene.

[26]  Q. Su,et al.  Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. , 2005, Cancer research.

[27]  Arie Perry,et al.  Notch1 and Notch2 Have Opposite Effects on Embryonal Brain Tumor Growth , 2004, Cancer Research.

[28]  Andrew P. Weng,et al.  Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.

[29]  R. Klein,et al.  Notch activation induces apoptosis in neural progenitor cells through a p53-dependent pathway. , 2004, Developmental biology.

[30]  P. Mckinnon,et al.  DNA ligase IV suppresses medulloblastoma formation. , 2002, Cancer research.

[31]  J. Aster,et al.  Notch Signaling in Cancer , 2002, Cancer biology & therapy.

[32]  W. El-Deiry.  Transactivation of Repair Genes by BRCA1 , 2002, Cancer biology & therapy.

[33]  M. Hatten,et al.  Activated Notch2 Signaling Inhibits Differentiation of Cerebellar Granule Neuron Precursors by Maintaining Proliferation , 2001, Neuron.

[34]  J. Aster,et al.  Notch signaling in leukemia , 2001, Annual review of pathology.

[35]  M. Ikawa,et al.  Cyclin G1 is involved in G2/M arrest in response to DNA damage and in growth control after damage recovery , 2001, Oncogene.

[36]  Jon C. Aster,et al.  Essential Roles for Ankyrin Repeat and Transactivation Domains in Induction of T-Cell Leukemia by Notch1 , 2000, Molecular and Cellular Biology.

[37]  David J Anderson,et al.  Transient Notch Activation Initiates an Irreversible Switch from Neurogenesis to Gliogenesis by Neural Crest Stem Cells , 2000, Cell.

[38]  E. Kieff,et al.  Oncogenic Forms of NOTCH1 Lacking Either the Primary Binding Site for RBP-Jκ or Nuclear Localization Sequences Retain the Ability to Associate with RBP-Jκ and Activate Transcription* , 1997, The Journal of Biological Chemistry.

[39]  R. Myers,et al.  Human Homolog of patched, a Candidate Gene for the Basal Cell Nevus Syndrome , 1996, Science.

[40]  K. Kinzler,et al.  The molecular basis of Turcot's syndrome. , 1995, The New England journal of medicine.

[41]  D. Beach,et al.  Cyclin G is a transcriptional target of the p53 tumor suppressor protein. , 1994, The EMBO journal.

[42]  F. Radtke,et al.  Notch signaling in solid tumors. , 2010, Current topics in developmental biology.

[43]  T. Pierfelice,et al.  Notch, neural stem cells, and brain tumors. , 2008, Cold Spring Harbor symposia on quantitative biology.

[44]  P. Kleihues,et al.  Null mutation of DNA strand break-binding molecule poly(ADP-ribose) polymerase causes medulloblastomas in p53(-/-) mice. , 2003, The American journal of pathology.